-transparent.png){kind=logo}
Thirty-five patients with recurrent and 25 patients with metastatic malignant melanoma after previous radical locoregional surgery were treated with DTIC at the Institute of Oncology in Kraków between 1976 and 1981. Complete and partial remissions were observed in 19/60, i.e., in 31% of the patients. Our results show an advantage for patients with locoregional recurrence, soft-tissue and lung metastases, provided that the largest deposit is no larger than 5 cm in diameter. There is little chance of remission in patients with liver and bone metastases.
Related Publications
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
May 1996,
Journal of the American Academy of Dermatology,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
January 2010,
The oncologist,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
October 2009,
The oncologist,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
November 1980,
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
September 1977,
Cancer,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
February 1979,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
January 1993,
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
May 1993,
Cancer,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
January 1984,
Investigational new drugs,
M Pawlicki, and
J Skołyszewski, and
B Stryjewska, and
H Nosek
August 2021,
Anticancer research,
